Stay updated on Fostamatinib in wAIHA Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in wAIHA Clinical Trial page.

Latest updates to the Fostamatinib in wAIHA Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe study record page now shows a 403 Forbidden error, blocking access to the content and preventing the study details from loading.SummaryDifference17%

- Check35 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, representing a change to the page's version history. This update does not alter any study details shown on the page.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision label on the page was updated from v3.6.4 to v3.6.5, signaling a small backend/ CMS update. The change does not affect study content or functionality.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the study page. This update indicates a version bump or minor content refresh without changing the displayed study information.SummaryDifference0.0%

- Check93 days agoChange DetectedFooter revision text updated from v3.6.2 to v3.6.3. This marks a minor version increment and does not modify the study details, eligibility criteria, or other page content.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page shows a revision update from v3.6.0 to v3.6.2, indicating a minor platform update with no changes to study information.SummaryDifference0.0%

Stay in the know with updates to Fostamatinib in wAIHA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in wAIHA Clinical Trial page.